Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.44% |
| Dec 31, 2025 | -9.99% |
| Sep 30, 2025 | -1.58% |
| Jun 30, 2025 | 17.18% |
| Mar 31, 2025 | 3.24% |
| Dec 31, 2024 | -4.52% |
| Sep 30, 2024 | 8.14% |
| Jun 30, 2024 | -5.11% |
| Mar 31, 2024 | 7.46% |
| Dec 31, 2023 | -8.34% |
| Sep 30, 2023 | 11.36% |
| Jun 30, 2023 | 8.54% |
| Mar 31, 2023 | 12.96% |
| Dec 31, 2022 | 15.39% |
| Sep 30, 2022 | 1.90% |
| Jun 30, 2022 | 6.93% |
| Mar 31, 2022 | -2.79% |
| Dec 31, 2021 | 15.69% |
| Sep 30, 2021 | -4.01% |
| Jun 30, 2021 | -2.42% |
| Mar 31, 2021 | 6.73% |
| Dec 31, 2020 | 10.89% |
| Sep 30, 2020 | -29.96% |
| Jun 30, 2020 | -38.42% |
| Mar 31, 2020 | -28.68% |
| Dec 31, 2019 | 2.09% |
| Sep 30, 2019 | -10.62% |
| Jun 30, 2019 | 4.07% |
| Mar 31, 2019 | -1.59% |
| Dec 31, 2018 | -20.71% |
| Sep 30, 2018 | 19.83% |
| Jun 30, 2018 | -7.88% |
| Mar 31, 2018 | -11.22% |
| Dec 31, 2017 | 7.23% |
| Sep 30, 2017 | 2.74% |